These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8020520

  • 1. Iomeprol and iopamidol in cardiac angiography: a randomised, double-blind, parallel-group comparison.
    Fattori R, Piva R, Schicchi F, Pancrazi A, Gabrielli G, Marzocchi A, Piovaccari G, Blandini A, Magnani B.
    Eur J Radiol; 1994 May; 18 Suppl 1():S61-6. PubMed ID: 8020520
    [Abstract] [Full Text] [Related]

  • 2. [Electrocardiographic and hemodynamic adverse effects of contrast media in coronary angiography].
    Wagner J, Zwicker B.
    Z Kardiol; 1994 Feb; 83(2):146-54. PubMed ID: 8165845
    [Abstract] [Full Text] [Related]

  • 3. Comparison of low osmolality ionic (ioxaglate) versus nonionic (iopamidol) contrast media in cardiac angiography.
    Wisneski JA, Gertz EW, Dahlgren M, Muslin A.
    Am J Cardiol; 1989 Feb 15; 63(7):489-95. PubMed ID: 2916435
    [Abstract] [Full Text] [Related]

  • 4. Iomeprol versus iopamidol in contrast-enhanced computed tomography of thoracic and abdominal organs.
    Valentini AL, Tartaglione T, Monti L, Marano P.
    Eur J Radiol; 1994 May 15; 18 Suppl 1():S88-92. PubMed ID: 8020525
    [Abstract] [Full Text] [Related]

  • 5. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation.
    Vijayalakshmi K, Kunadian B, Wright RA, Hall JA, Stewart MJ, Davies A, Sutton A, de Belder MA.
    Eur J Radiol; 2007 Feb 15; 61(2):342-50. PubMed ID: 17101256
    [Abstract] [Full Text] [Related]

  • 6. Double-blind comparison of safety and efficacy of iomeprol and iopamidol in carotid digital subtraction angiography.
    Beltramello A, Piovan E, Rosta L.
    Eur J Radiol; 1994 May 15; 18 Suppl 1():S67-72. PubMed ID: 8020521
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection.
    Schmid I, Didier D, Pfammatter T, Garachemani A, Fleisch M, Kirchin MA, Meier B.
    Int J Cardiol; 2007 Jun 12; 118(3):389-96. PubMed ID: 17376548
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical utility and safety profile of iomeprol.
    Rosati G.
    Eur J Radiol; 1994 May 12; 18 Suppl 1():S120-4. PubMed ID: 8020514
    [Abstract] [Full Text] [Related]

  • 11. Peripheral arteriography with a new nonionic agent: comparison of iomeprol with iopamidol.
    Ugolotti U, Larini P, Marcato C, Cusmano F, Puccianti F.
    Eur J Radiol; 1994 May 12; 18 Suppl 1():S77-82. PubMed ID: 8020523
    [Abstract] [Full Text] [Related]

  • 12. Iomeprol: current and future profile of a radiocontrast agent.
    Katayama H, Spinazzi A, Fouillet X, Kirchin MA, Taroni P, Davies A.
    Invest Radiol; 2001 Feb 12; 36(2):87-96. PubMed ID: 11224756
    [Abstract] [Full Text] [Related]

  • 13. [Hemodynamic effects of non-ionic iomeprol 350 and ionic diatrizoate 370 during levocardiography and coronary angiography--double-blind randomized comparison of 2 contrast media].
    Lins M, Röhling D, Zahorsky R, Höfig M, Herrmann G, Simon R.
    Z Kardiol; 1994 Sep 12; 83(9):626-33. PubMed ID: 7801664
    [Abstract] [Full Text] [Related]

  • 14. Clinical usefulness of iomeprol 400 mgl/ml in cardioangiography evaluation of patient discomfort and hemodynamic and ECG effects.
    Himi K, Takemoto A, Himi S, Tanaka Y, Hirayama T, Katayama Y, Tomaru T.
    Acad Radiol; 1998 Apr 12; 5 Suppl 1():S54-7. PubMed ID: 9561044
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of the radiographic efficacy of iomeprol.
    Kozuka T, Katayama H, Ebata K.
    Eur J Radiol; 1994 May 12; 18 Suppl 1():S109-14. PubMed ID: 8020512
    [Abstract] [Full Text] [Related]

  • 16. Iomeprol: a review of its use as a contrast medium.
    Dooley M, Jarvis B.
    Drugs; 2000 May 12; 59(5):1169-86. PubMed ID: 10852647
    [Abstract] [Full Text] [Related]

  • 17. A double-blind comparative study of the safety and efficacy of iomeprol in renal intra-arterial digital subtraction angiography.
    Simonetti G, Guazzaroni M, Carpanese L, Canalis GC, Urigo F.
    Eur J Radiol; 1994 May 12; 18 Suppl 1():S73-6. PubMed ID: 8020522
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamic effects of iomeprol for injection in experimental animals.
    Cipolla P, Tirone P, Luzzani F, de Haën C.
    Eur J Radiol; 1994 May 12; 18 Suppl 1():S32-42. PubMed ID: 8020517
    [Abstract] [Full Text] [Related]

  • 19. Pain in femoral arteriography. A double-blind, randomized, clinical study comparing safety and efficacy of the iso-osmolar iodixanol 270 mgI/ml and the low-osmolar iomeprol 300 mgI/ml in 9 European centers.
    Manke C, Marcus C, Page A, Puey J, Batakis O, Fog A.
    Acta Radiol; 2003 Nov 12; 44(6):590-6. PubMed ID: 14616202
    [Abstract] [Full Text] [Related]

  • 20. A multicenter randomized trial of ionic (ioxaglate) and nonionic (iopamidol) low-osmolality contrast agents in cardiac angiography.
    Klinke WP, Grace M, Miller R, Naqvi SZ, Roth D, Roy L.
    Clin Cardiol; 1989 Dec 12; 12(12):689-96. PubMed ID: 2692891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.